FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/066163 [Registered on: 23/04/2024] Trial Registered Prospectively
Last Modified On: 21/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   This study is being conducted to compare two doses of intravenous dexamethasone for prolongation of analgesia in axillary block in patient undergoing mid arm surgeries  
Scientific Title of Study   A Placebo Controlled study to compare two doses of intra-venous dexamethasone for Prolongation of analgesia in axillary Brachial plexus block . 
Trial Acronym  Nil  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mangal Ahlawat 
Designation  Associate professor  
Affiliation  PGIMS Rohtak  
Address  Department of Anaesthesiology and critical care .PGIMS rohtak pt.b.d sharma University of health sciences

Rohtak
HARYANA
124001
India 
Phone  9812989930  
Fax    
Email  drmangalahlawat@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mangal Ahlawat 
Designation  Associate professor  
Affiliation  PGIMS Rohtak  
Address  Department of Anaesthesiology and critical care .PGIMS rohtak pt.b.d sharma University of health sciences

Rohtak
HARYANA
124001
India 
Phone  9812989930  
Fax    
Email  drmangalahlawat@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mangal Ahlawat 
Designation  Associate professor  
Affiliation  PGIMS Rohtak  
Address  Department of Anaesthesiology and critical care .PGIMS rohtak pt.b.d sharma University of health sciences

Rohtak
HARYANA
124001
India 
Phone  9812989930  
Fax    
Email  drmangalahlawat@gmail.com  
 
Source of Monetary or Material Support  
Pt.BD sharma PGIMS rohtak 
 
Primary Sponsor  
Name  PGIMS ROHTAK pt.B.D sharma University of health sciences  
Address  Department of anesthesiology and critical care at pt.b.d Sharma pgims rohtak Pin-124001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrPriyanka Rani  Pr BD sharma PGIMS rohtak   Department of Anaesthesiology and critical care Pgims rohtak PT bd sharma University of health sciences. Pin-124001
Rohtak
HARYANA 
9468316541

Pinkumew222@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Biomedical research ethics committee PGIMS rohtak   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: O||Medical and Surgical, (3) ICD-10 Condition: S529||Unspecified fracture of forearm,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ultrasound guided axillary brachial plexus block is given in all patients undergoing below mid arm surgeries   All block will be performed with sono site Edge 2 ultrasound machine using high frequency (6-13)Mhz linear probe .Block was performed with 23G needle in both the groups .In plane technique is used ,in which entire shaft and tip of needle will be visible .All injection are given with 10ml of 0.5%bupivacaine +2%lignocaine with adrenaline(1:200,000) after confirming negative aspiration and no parasthesia .5ml of local anaesthetic drug mixture will be deposited around musculocutaneous nerve and rest of local anaesthetic mixture will be deposited anterior and posterior to axillary artery . Onset and efficacy of motor and sensory blockage will be assess at 5min 10min,30min after block . 
Comparator Agent  We compare two different dosage of intravenous dexamethasone 4mg vs 8mg in prolongation of analgesia in ultrasound guided axillary brachial plexus block .  We first put ultrasound guided axillary brachial block and we assess onset of sensory and motor blockage At 5min ,10min ,30min after block . If found satisfactory effect of block at 30min after block then intravenous dexamethasone 4mg vs 8mg or intravenous NS to be administered as per group allocation . Analgesic effect will be assess at baseline ,every hourly till 4 hours and then every 30min till 6 hours.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  ASA I-III patients undergoing elective below mid arm surgeries under axillary Brachial plexus block and duration of surgery should be less than 3 hours  
 
ExclusionCriteria 
Details  1)local infection at injection site or sepsis
2)allergy to any local anaesthetic
3)pt.with known coagulopathy or an anticoagulant therapy
4)pt with GERD,cataract ,glaucoma
5)steroid use within 2 weeks of study period
6)systemic fungal infection ,viral infection
7)patient with nerve entrapment or neuropathy after trauma or diabetic neuropathy and uncontrolled diabetes.
8)patient who refuse to give consent
5) 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Duration of analgesia is compared between 3 groups of axillary brachial plexus block.
1)d0-i/v NS given
2)d1-i/v 4mg dexamethasone given
3)d2-i/v 8mg dexamethasone given  
We will assess efficacy of block at 30min after block .
We will assess VAS score at
1)Baseline(preblock)
2) every 1 hourly till 4 hours
3) every 30min till 6 hours
4) 24 hour  
 
Secondary Outcome  
Outcome  TimePoints 
1)Block characteristics (onset and duration )
2)no.of attempt taken for block
3)duration of sensory block
4)duration of motor block
5)VAS
6)Any complications 
1)sensory block duration is time in minutes from end of local anaesthesia injection till return of hand and finger sensation (ts)
2)motor block duration is time in minutes from end of local anaesthesia injection till return of hand and finger movement(TM)
3)VAs ( 0-100) acess at before block ,30min after block ,every 1hourly till 4 hour ,then every 30 min interval till next 2 hour . 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   10/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="6" 
Recruitment Status of Trial (Global)   Closed to Recruitment of Participants 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   It is a Placebo Controlled study in which we compare 2 doses of I/v dexamethasone (4mg vs 8mg) for Prolongation of analgesia in axillary brachial plexus block .written informed consent will be taken from all the patients.Data will be compiled and analysed with good statistical test . 
Close